slu pp 332 and 5 amino 1mq slu-pp-332 vs 5-amino-1mq oral vs injection Peptide Therapy SLU-PP-332 Scientific Overview: Mechanism, Research,

Post-hoc comparisons showed that the Firmicutes phylums relative abundance was significantly higher in WD control mice compared to mice in the vehicle- and 5A-1MQ-treated groups switched from WD to LD (Fig

But you can also have a vitamin B12 deficiency without having anemia

The key findings from this clinical program include significant reductions in body weight and fat mass in treatment groups compared to placebo, preferential loss of abdominal and visceral adipose tissue, no changes in serum IGF-1 levels at any dose tested, no negative effects on glucose metabolism or insulin sensitivity, no significant adverse events related to metabolic or endocrine disruption, and safety profile indistinguishable from placebo for most parameters

Considering sublingual tablets or nasal spray for better absorption